Rapid Response COV-19C25 COVID-19 Antigen Rapid Test Device User Guide

Learn about the Rapid Response COV-19C25 COVID-19 Antigen Rapid Test Device. This in vitro immunochromatographic assay detects SARS-CoV-2 viral nucleoprotein antigens in nasal and nasopharyngeal secretions, providing direct and qualitative results within 6 days of symptom onset. With authorized use in patient care settings, this test aids in identifying infection status and informing patient management decisions.